|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||138.14 - 138.84|
|52 Week Range||114.07 - 139.37|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.06%|
Hopes for Trump's tax reforms, abating North Korea fears, lower-than-expected damage from Hurricane Irma and record stock market highs rekindled the love for U.S. equity ETFs last week.
Acadia Pharmaceuticals' (ACAD) commercial teams have been carrying out promotional efforts to create awareness for Nuplazid among physicians with the intent to have them prescribe the drug.
Since demand from the target population for prophylaxis is rising rapidly, Bioverativ’s Alprolix and Eloctate are expected to see solid demand trends in 2017.
About 40% of patients succumb to heart failure within five years. Abiomed believes that it is reperfusion injuries that cause these problems.
In 1Q17, Align Technology (ALGN) has started selling its new product Invisalign Go in North America, which involves a few DSOs (dental service organizations).
Here's how exchange-traded funds work, why they benefit retail investors, and how to pick the right ETFs for your portfolio.
|CBOE Holdings Inc||CBOE||0.32%|
|Cadence Design Systems Inc||CDNS||0.31%|
|Packaging Corp of America||PKG||0.30%|
|Diamondback Energy Inc||FANG||0.28%|
|CoStar Group Inc||CSGP||0.27%|
|Atmos Energy Corp||ATO||0.27%|
|Broadridge Financial Solutions Inc||BR||0.26%|